Related Experiment Video
Updated: Jan 28, 2026

A Computer-assisted Multi-electrode Patch-clamp System
Published on: October 18, 2013
The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT): A Multi-Phase Program Overview
Linda E Carlson1, Harriet Richardson2, Ron Shore3,4
1Division of Psychosocial Oncology, Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 2T8, Canada.
The Canadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT) network will improve supportive care for advanced cancer patients facing demoralization syndrome. It aims to build capacity, generate evidence, and inform policy for equitable access to psychedelic-assisted therapy (PAT).
Area of Science:
- Oncology
- Psychiatry
- Health Services Research
Background:
- Demoralization syndrome and psychosocial distress are significant challenges for Canadians with advanced cancer.
- Existing supportive care models often fail to adequately address these complex needs.
- Psychedelic-assisted therapy (PAT) shows promise for improving quality of life in palliative care settings.
Purpose of the Study:
- To establish the Canadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT) to address gaps in supportive cancer care.
- To develop a national network for research, training, and policy development in PAT for cancer patients.
- To prepare Canada's oncology healthcare system for the potential implementation of PAT.
Main Methods:
- CAN-PACT's strategy involves environmental scans, stakeholder engagement, and developing interdisciplinary networks.
- The program includes developing training and education for clinicians, researchers, and patients.
- A multi-center, randomized controlled trial of PAT for advanced cancer patients is planned, alongside feasibility pilot testing.
Main Results:
- The network aims to set research priorities through structured stakeholder engagement.
- CAN-PACT will pilot test intervention and assessment procedures for feasibility.
- A multi-center randomized controlled trial will assess the efficacy of PAT for advanced cancer patients.
Conclusions:
- CAN-PACT aims to enable equitable access to safe, evidence-based PAT for advanced cancer patients in Canada.
- The network will build capacity and generate Canadian evidence to support PAT implementation.
- Collaboration with policymakers is key to influencing healthcare policy on PAT in Canada.
Related Concept Videos
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Phase I Oxidative Reactions: Overview
Phase II Conjugation Reactions: Overview
Hallucinogens and Psychedelics
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Targeted Cancer Therapies
There are several types of targeted therapies against...

